Home HOMEPAGE   Fri, 03/29/2024 GMT + 7
    Q & A   Site map Forum   Site map Sitemap   E-mali Contact   Vietnamese Vietnamese
IMPE-QN
Web Sites & Commerce News - Events
Web Sites & Commerce Introduction
Web Sites & Commerce Collaborative activities
Web Sites & Commerce Training
Web Sites & Commerce Specific research studies
Web Sites & Commerce Publications
Web Sites & Commerce Mass organization activities
Web Sites & Commerce Legal documents
Web Sites & Commerce Statistical data
Web Sites & Commerce Work safety
Web Sites & Commerce Vietnam`s Physicians
Web Sites & Commerce Malariology
Web Sites & Commerce Helminthology
Finance & Retail Other vector-borne diseases
Dengue fever/ Dengue Haemorrhagic Fever
Japanese Encephalisis B
Vectors of Lymphatic Filariasis
Acarology ( tichk, fleas, house-dust mistes)

SEARCH

LOGIN
Username
Password

WEBLINKS
Other links

Visiting users: 413
5 2 5 2 1 1 9 8
Online
4 1 3
 Other vector-borne diseases Dengue fever/ Dengue Haemorrhagic Fever
Mexico to get world's first dengue fever vaccine

Mexico has approved the use of the world's first vaccine against dengue fever, the health ministry announced.

The deadliest form of the mosquito-borne disease kills 22,000 people per year, according to the World Health Organisation.

French pharmaceutical company Sanofi said it developed the vaccine, Dengvaxia, over the past 20 years.

Some 40,000 people will receive the treatment in Mexico in an initial phase.

"With this decision, Mexico moves ahead of all other countries, including France, to tackle the spread of this virus," said the health ministry in a statement.


 
Dengue fever is spread by the Aedes aegypti mosquito


'Public health history'

Dengue fever affects more than 400 million people a year across the world, mainly urban areas in tropical and sub-tropical climates.

It is a leading cause of hospital admissions in most Latin American and Asian countries, says the WHO. Most of the victims are children.

The vaccine will be available o­nly to children over the age of nine, and adults under 49 who live in areas where the disease is endemic.

It is designed to prevent four types of dengue virus, said Sanofi.

"It's a very important moment in the history of public health," the head of Sanofi Vaccines Division, Olivier Charmeil, told the AFP new agency.

The company said it spent more than $1.6bn (£1bn) developing and creating the treatment.

The symptoms of dengue fever are similar to those of a severe flu.

It is transmitted from person to person by the Aedes aegypti mosquito, which also spreads chikungunya, zika fever and other diseases.

The first cases of dengue were registered in the 1950s in Thailand and the Philippines.

 

12/10/2015
(Source: bbc.com)  

Announcement

LIBRARY
Book
Magazine
Document
Photos
Thesis
Documentary form
Research studies
PROFFESSIONAL SOFTWARE
Malaria forecast & management
Document management
Personel management
LEGAL DOCUMENTS
Law
Decision
Decree
Instruction
Circular
Official document
Reports
Others
SPECIFIED IMFORMATION
Malaria facts
Malaria epidemic
Petechial fever
HEALTH SERVICES
Hospital & medical centre
Drugstore
Surgery
Your doctor

Institue of Malariology Parastology and Entomology Quy Nhon
Address: 611B Nguyen Thai Hoc Str,. Quy Nhon City
Tel: (84) 056 846571 Fax: (84) 056 846755
• Designed by Quang Ich JSC